2031.2000 -20.60 (-1.00%)
NSE Sep 17, 2025 15:49 PM
Volume: 672.3K
 

2031.20
-1.00%
Lupin gets UK nod to launch generic asthma inhaler drug Fostair
Moneycontrol
Respiratory diseases affect one in five people. It is the third biggest cause of death in the UK and is a clinical priority for the NHS.
More from Lupin Ltd.
Recommended